Company intelligence / Profile preview

Accelerator Life Science Partners

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

Accelerator Life Science Partners is an early-stage life science accelerator and investment firm rather than a therapeutic company. It creates and builds next-generation biotechnology companies by providing business, scientific, and financial support. ALSP has successfully launched multiple companies including Rodeo Therapeutics (acquired by Amgen for up to $721M in 2021), Petra Pharma (acquired by a global pharmaceutical company in 2020), and Lodo Therapeutics (acquired by Zymergen/Ginkgo BioWorks).

Industry: Investors

Partnerships

Perceptive AdvisorsAmgenGenentechEli Lilly and CompanyClavystBioEDBIXora Innovation

Beyond the preview

Go deeper on Accelerator Life Science Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accelerator Life Science Partners.

Explore the full profile